Mucus physicochemical properties in children with ulcerative colitis;Właściwości fizykochemiczne śluzu u dzieci z wrzodzieja̧cym zapaleniem jelita grubego

Polski Merkuriusz Lekarski

Volumn 17, Issue SUPPL. 1, 2004, Pages 19-21

  Grzybowska, Krystyna ^a,b   Gwoździński, Krzysztof ^c   Zaleśna, Grazyna ^c   Kisiel, Anna ^a   Grzybowski, Piotr ^a   Płaneta Małecka, Izabela ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b Klinika Immunologii   (Poland)

^c Zaklad Badan Strukt Biopolimerow UL ^*

Author keywords

Mucus; Ulcerative colitis

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; DISEASE MARKER; DISEASE SEVERITY; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; MALE; MUCUS; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT; SCHOOL CHILD; SPECTROPHOTOMETRY; ULCERATIVE COLITIS; VISCOSITY;

ADOLESCENT; CHILD; COLITIS, ULCERATIVE; COLON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INTESTINAL MUCOSA; MAGNETICS; MALE; MUCUS; PROTEINS; SPECTROPHOTOMETRY;

EID: 4544227480     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 14C-glucosamine relative to 3H-N-acetylglucosamine in the intestinal mucosa of patients with inflammatory bowel disease. Am. J. Gastroenterol., 1983, 78, 19-22.
2. Clamp J.R., Fraser G., Read A.E.: Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin. Sci., 1981, 61, 229-234.
3. Corfield A.P., Myerscough N., Longman R. i wsp.: Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut, 2000, 47 (4), 589-594.
4. Einerhand A.W., Renes I.B., Makkink M.K. i wsp.: Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur. J. Gastroenterol. Hepatol., 2002, 14 (7), 757-765.
5. Faure M., Moennoz D., Montigon F. i wsp.: Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig. Dis. Sci. 2003, 48 (7), 1366-1376.
6. Franzin G., Grigioni W.F., Dina R. i wsp.: Mucin secretion and morphological changes of the mucosa in non-neoplastic disease the colon. Histipathology, 1983, 7, 707-718.
7. Leammli U.K.: Clavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
8. Lowry J.O.H., Rosenbrough N.J., Farr R.L. i wsp.: Protein measurement with the folin phenol reagent. J. Biol. Ch., 1951, 193, 265-275.
9. McCormick D.A., Horton L.W., Mee A.S.: Mucin depletion in inflammatory bowel disease. J. Clin. Pathol., 1990, 43, 143-146.
10. Oshitani N. i wsp. Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand. J. Gastroenterol., 1995, 30, 915-920.
11. Reid C.J., Harris A.: Developmental expression of mucin genes in the human gastrointestinal system. Gut, 1988, 42, 220-226.
12. Rhodes J.M.: Mucins and inflammatory bowel disease. QJM, 1997, 90 (2), 9-82.
13. Scholmerich J.: Inflammatory bowel disease at the end of its first century. Heaptogastroenterology, 2000, 47, 2-4.
14. Shirazi T., Longman RJ., Corfield A.P. i wsp.: Mucins and inflammatory bowel disease. Postgrad. Med. J., 2000, 76 (898), 473-478.
15. Snyder J.D., Walker W.A.: Structure and function of intestinal mucin: developmental aspects. Int. Arch. Allergy Appl. Immunol., 1987, 82 (3-4), 351-356.
16. Truelove S.C., Wilts L.J.: Cortisone in ulcerative colitis. Final report on a therapeutical trial. Brit. Med. J., 1955, 2, 1041-1048.
17. Tytgat K.M.A.J., Buller H.A., Opdam F.J.M. i wsp.: Biosynthesis of human colonic mucin:MUC2 is the prominent secretory mucin. Gastroenterology, 1994, 107, 1352-1363.